Literature DB >> 19692589

Mechanisms for transcellular diapedesis: probing and pathfinding by 'invadosome-like protrusions'.

Christopher V Carman1.   

Abstract

Immune-system functions require that blood leukocytes continuously traffic throughout the body and repeatedly cross endothelial barriers (i.e. diapedese) as they enter (intravasate) and exit (extravasate) the circulation. The very earliest studies to characterize diapedesis directly in vivo suggested the coexistence of two distinct migratory pathways of leukocytes: between (paracellular pathway) and directly through (transcellular pathway) individual endothelial cells. In vivo studies over the past 50 years have demonstrated significant use of the transcellular diapedesis pathway in bone marrow, thymus, secondary lymphoid organs, various lymphatic structures and peripheral tissues during inflammation and across the blood-brain barrier and blood-retinal barrier during inflammatory pathology. Recently, the first in vitro reports of transcellular diapedesis have emerged. Together, these in vitro and in vivo observations suggest a model of migratory pathfinding in which dynamic 'invadosome-like protrusions' formed by leukocytes have a central role in both identifying and exploiting endothelial locations that are permissive for transcellular diapedesis. Such 'probing' activity might have additional roles in this and other settings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692589     DOI: 10.1242/jcs.047522

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  78 in total

Review 1.  Peeking into the secret life of neutrophils.

Authors:  Jackson LiangYao Li; Lai Guan Ng
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 2.  Breaching multiple barriers: leukocyte motility through venular walls and the interstitium.

Authors:  Sussan Nourshargh; Peter L Hordijk; Michael Sixt
Journal:  Nat Rev Mol Cell Biol       Date:  2010-05       Impact factor: 94.444

3.  Comparison of immortalized bEnd5 and primary mouse brain microvascular endothelial cells as in vitro blood-brain barrier models for the study of T cell extravasation.

Authors:  Oliver Steiner; Caroline Coisne; Britta Engelhardt; Ruth Lyck
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-07       Impact factor: 6.200

Review 4.  Recent insights into endothelial control of leukocyte extravasation.

Authors:  Peter L Hordijk
Journal:  Cell Mol Life Sci       Date:  2016-01-21       Impact factor: 9.261

5.  An Endothelial Planar Cell Model for Imaging Immunological Synapse Dynamics.

Authors:  Roberta Martinelli; Christopher V Carman
Journal:  J Vis Exp       Date:  2015-12-24       Impact factor: 1.355

6.  Leukocyte transcellular diapedesis: Rap1b is in control.

Authors:  Marie-Dominique Filippi
Journal:  Tissue Barriers       Date:  2015-05-21

7.  Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain.

Authors:  Dongfen Yuan; Yuling Zhao; William A Banks; Kristin M Bullock; Matthew Haney; Elena Batrakova; Alexander V Kabanov
Journal:  Biomaterials       Date:  2017-07-10       Impact factor: 12.479

Review 8.  Myosin light chain kinase in microvascular endothelial barrier function.

Authors:  Qiang Shen; Robert R Rigor; Christopher D Pivetti; Mack H Wu; Sarah Y Yuan
Journal:  Cardiovasc Res       Date:  2010-05-17       Impact factor: 10.787

9.  A chemokine self-presentation mechanism involving formation of endothelial surface microstructures.

Authors:  Catherine Whittall; Oksana Kehoe; Sophie King; Antal Rot; Angela Patterson; Jim Middleton
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

10.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions.

Authors:  Alessandro Parodi; Nicoletta Quattrocchi; Anne L van de Ven; Ciro Chiappini; Michael Evangelopoulos; Jonathan O Martinez; Brandon S Brown; Sm Z Khaled; Iman K Yazdi; Maria Vittoria Enzo; Lucas Isenhart; Mauro Ferrari; Ennio Tasciotti
Journal:  Nat Nanotechnol       Date:  2012-12-16       Impact factor: 39.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.